← Back to Search

Anti-tumor antibiotic

Eribulin ORA for Solid Tumors

Phase 1
Waitlist Available
Research Sponsored by Athenex, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Study Summary

This trial is testing a new cancer drug to find the best dose and to see if it is safe.

Eligible Conditions
  • Solid Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dose Escalation: Maximum Tolerated Dose
Dose Expansion: Occurrence of Grade 3 and 4 treatment-related adverse
Secondary outcome measures
Dose Escalation: Bioavailability
Dose Escalation: Safety
Dose Escalation: Tumor Response

Trial Design

1Treatment groups
Experimental Treatment
Group I: Eribulin ORAExperimental Treatment1 Intervention
To determine the MTD of Eribulin ORA (oral eribulin mesylate and HM30181A) when administered on Day 1 and Day 8 of a 3 weeks cycle.

Find a Location

Who is running the clinical trial?

Athenex, Inc.Lead Sponsor
26 Previous Clinical Trials
1,958 Total Patients Enrolled
David Cutler, MDStudy DirectorAthenex, Inc.
10 Previous Clinical Trials
665 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluate Eribulin ORA in Subjects With Solid Tumors
2019. "Evaluate Eribulin ORA in Subjects With Solid Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04013217.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top